Skip to main content
. 2021 Dec 31;16(12):e0261983. doi: 10.1371/journal.pone.0261983

Fig 2. Prevalence and incidence rates per 100,000 persons in neuromuscular disease 2000–2019.

Fig 2

(A) Females. (B) Males. Dark Blue = Lifetime prevalence rate per 100,000 persons. Light Blue = Lifetime prevalence rate per 100,000 persons excluding Guillain-Barré syndrome codes not recorded in previous 5 years. Red = Incidence rate per 100,000 person-years. Both rates age standardised to CPRD population as of 1/1/2019. 95% confidence intervals shown for each.